We correlated TK1 expression with clinicopathological characteristics of the tumors and survival outcomes, with the aim to better understand the role of TK1 in BC biology and to suggest it as a useful biomarker in the stratification of BC patients’ prognosis. This evidence concerns the gene TK1 and breast cancer.